Esperion Therapeutics Provides Clinical Development and Regulatory Update for Bempedoic Acid
28. Juni 2016 16:05 ET
|
Esperion Therapeutics, Inc.
On track to initiate global pivotal Phase 3 studies and CVOT in the fourth quarter Aligned with global regulatory authorities on a consistent definition of statin intolerance Conference...